NO135092B - - Google Patents

Download PDF

Info

Publication number
NO135092B
NO135092B NO2498/73A NO249873A NO135092B NO 135092 B NO135092 B NO 135092B NO 2498/73 A NO2498/73 A NO 2498/73A NO 249873 A NO249873 A NO 249873A NO 135092 B NO135092 B NO 135092B
Authority
NO
Norway
Prior art keywords
methoxy
chlorobenzamide
amino
acetamino
diethylaminoethyl
Prior art date
Application number
NO2498/73A
Other languages
Norwegian (no)
Other versions
NO135092C (en
Inventor
G Bulteau
J Acher
J-C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NO135092B publication Critical patent/NO135092B/no
Publication of NO135092C publication Critical patent/NO135092C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Description

Foreliggende oppfinnelse angår en ny fremgangsmåte ved fremstilling av N-(diethylaminoethyl)-2-methoxy-4-amino-5-klorbenzamid (IV), dets syreaddisjonssalter med farmasøytisk aksep- The present invention relates to a new process for the production of N-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide (IV), its acid addition salts with pharmaceutical acceptance

table uorganiske eller organiske syrer, og kvartære ammonium- table inorganic or organic acids, and quaternary ammonium

salter derav fremstilt ved omsetning av benzamidet med et alkyl-eringsmiddel. salts thereof prepared by reacting the benzamide with an alkylating agent.

Benzamidet av formel (IV) fremstilles ved at en ester av 2-methoxy-4-acetamino-5-klorbenzosyre (I) behandles med et ethanolamin under dannelse av N-(2-hydroxyethyl)-2-methoxy-4-acetamino-5-klorbenzamid (II). Når denne forbindelse behandles med thionylklorid, erholdes det N-(2-klorethyl)-2-methoxy-4-amino-5-klorbenzamid (III) som omsettes med diethylamin under dannelse av det ønskede N-(diethylaminoethyl)-2-methoxy-4-amino-5-klorbenzamid (IV) . The benzamide of formula (IV) is prepared by treating an ester of 2-methoxy-4-acetamino-5-chlorobenzoic acid (I) with an ethanolamine to form N-(2-hydroxyethyl)-2-methoxy-4-acetamino-5 -chlorobenzamide (II). When this compound is treated with thionyl chloride, N-(2-chloroethyl)-2-methoxy-4-amino-5-chlorobenzamide (III) is obtained, which is reacted with diethylamine to form the desired N-(diethylaminoethyl)-2-methoxy- 4-amino-5-chlorobenzamide (IV) .

Dette kjente benzamid har gode farmakologiske egenskaper This known benzamide has good pharmacological properties

som antiemetisk middel og som et modifiserende middel ved fordøy-elsesprosessen. as an antiemetic agent and as a modifying agent in the digestive process.

Reaksjonsdiagrammet er som følger: The reaction diagram is as follows:

Det følgende eksempel illustrerer oppfinnelsen. The following example illustrates the invention.

N-( diethylaminoethyl)- 2- methoxy- 4- amino- 5- klorbenzamid N-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide

Trinn I: N-(2-hydroxyethyl)-2-methoxy-4-acetamino-5-klorbenzamid Step I: N-(2-hydroxyethyl)-2-methoxy-4-acetamino-5-chlorobenzamide

200 g (0,78 mol) methyl-2-methoxy-4-acetamino-5-klorbenzoat, 57 g (0,93 mol) ethanolamin, 460 ml xylen og 20 g aluminium iso-propylat ble innført i en 2 liters kolbe utstyrt med rører, 200 g (0.78 mol) methyl-2-methoxy-4-acetamino-5-chlorobenzoate, 57 g (0.93 mol) ethanolamine, 460 ml xylene and 20 g aluminum isopropylate were introduced into a 2 liter flask equipped with pipes,

kjøler, termometer og destillasjonsanordning. cooler, thermometer and distillation device.

Blandingen ble oppvarmet i 3 timer under tilbakeløpskjøl-ing, avkjølt, og den øvre fase ble dekantert fra, oljen ble løst i 500 ml dioxan, og de uløselige bestanddeler ble filtrert fra og løsningsmidlet fordampet. The mixture was heated for 3 hours under reflux, cooled, and the upper phase was decanted, the oil was dissolved in 500 ml of dioxane, and the insolubles were filtered off and the solvent was evaporated.

Residuet ble delvis løst i'acetonitril. Løsningen fikk stå over natten i et kjøleskap og ble derefter filtrert og løsnings-midlet fordampet. Det ble erholdt 89 g N-(2-hydroxyethyl)-2- The residue was partially dissolved in acetonitrile. The solution was allowed to stand overnight in a refrigerator and was then filtered and the solvent evaporated. 89 g of N-(2-hydroxyethyl)-2-

methoxy-4-acetamino-5-klorbenzamid med smeltepunkt 170°C. methoxy-4-acetamino-5-chlorobenzamide with melting point 170°C.

Trinn II: N-( 2- klorethyl)- 2- methoxy- 4- amino- 5- klorbenzamid 3 g (0,01 mol) N-(2-hydroxyethyl)-2-methoxy-4--acetamino-5-klorbenzamid og 15 ml thionylklorid ble innført i en 100 ml kolbe utstyrt med rører, termometer og kjøler, og blandingen ble omrørt i 7 timer ved omgivende temperatur. Step II: N-(2-chloroethyl)-2-methoxy-4-amino-5-chlorobenzamide 3 g (0.01 mol) N-(2-hydroxyethyl)-2-methoxy-4--acetamino-5-chlorobenzamide and 15 ml of thionyl chloride were introduced into a 100 ml flask equipped with a stirrer, thermometer and condenser, and the mixture was stirred for 7 hours at ambient temperature.

Thionylkloridet ble fordampet under vakuum, residuet ble vasket med vann og filtrert, vasket med natriumhydroxyd, igjen filtrert og vasket med vann og derefter tørket, i en eksikator under vakuum i nærvær av kaliumhydroxyd. The thionyl chloride was evaporated under vacuum, the residue was washed with water and filtered, washed with sodium hydroxide, again filtered and washed with water and then dried, in a desiccator under vacuum in the presence of potassium hydroxide.

Det ble erholdt 2,80 g N-(2-klorethyl)-2-methoxy-4-amino-5-klorbenzamid med smeltepunkt l40°C. 2.80 g of N-(2-chloroethyl)-2-methoxy-4-amino-5-chlorobenzamide with a melting point of 140°C were obtained.

Trinn III: N-(diethylaminoethyl)-2-methoxy-4-amino-5-klorbenzamid - » Step III: N-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide - »

2,5 g (0,0095 mol) N-(2-klorethyl)-2-methoxy-4-amino-5-klorbenzamid og 35 ml diethylamin ble innført i en 50 ml kolbe utstyrt med kjøler og rører, og blandingen ble kokt under tilbakeløp i 3 dager. 2.5 g (0.0095 mol) of N-(2-chloroethyl)-2-methoxy-4-amino-5-chlorobenzamide and 35 mL of diethylamine were introduced into a 50 mL flask equipped with a condenser and stirrer, and the mixture was boiled under reflux for 3 days.

Blandingen ble avkjølt og filtrert, og filtratet ble fordampet. Residuet ble løst i 18 ml N saltsyre fulgt av filtrer-ing og vasking med vann, og løsningen ble gjort alkalisk med The mixture was cooled and filtered, and the filtrate was evaporated. The residue was dissolved in 18 ml of N hydrochloric acid followed by filtration and washing with water, and the solution was made alkaline with

20 ml 40%-ig natriumhydroxyd. 20 ml of 40% sodium hydroxide.

20 ml vann ble tilsatt, og løsningen ble kokt under til-bakeløp i 1,5 time. 20 ml of water was added and the solution was refluxed for 1.5 hours.

Reaksjonsblandingen ble avkjølt, filtrert, og produktet ble The reaction mixture was cooled, filtered, and the product was

omkrystallisert fra benzen. recrystallized from benzene.

Det ble erholdt 0,7 9 N-(diethylaminoethyl)-2-methoxy-4-amino-5-klorbenzamid med smeltepunkt l43°C. 0.79 N-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide with a melting point of 143°C was obtained.

Claims (2)

1. Fremgangsmåte ved fremstilling av N-(diethylaminoethyl)-2-methoxy-4-amino-5-klorbenzamid med formel: og syreaddisjonssalter med farmasøytisk akseptable uorganiske eller organiske syrer, og kvartære ammoniumsalter derav, karakterisert ved at en ester av 2-methoxy-4-acetamino-5-klorbenzosyre av generell formel: hvor R er en alkylgruppe med 1-3 carbonatomer, omsettes med ethanolamin, hvorefter det resulterende N-(2-hydroxyethyl)-2-methoxy-4-acetamino-5-klorbenzamid behandles med thionylklorid under dannelse av N-(2-klorethyl)-2-methoxy-4-amino-5-klorbenzamid, som omsettes med diethylamin under dannelse av N-(diethyl-aminoethyl)-2-methoxy-4-amino-5-klorbenzamid, som eventuelt om-dannes til et syreaddisjonssalt eller et kvartært ammoniumsalt.1. Procedure for the production of N-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide with formula: and acid addition salts with pharmaceutically acceptable inorganic or organic acids, and quaternary ammonium salts thereof, characterized in that an ester of 2-methoxy-4-acetamino-5-chlorobenzoic acid of general formula: where R is an alkyl group with 1-3 carbon atoms, is reacted with ethanolamine, after which the resulting N-(2-hydroxyethyl)-2-methoxy-4-acetamino-5-chlorobenzamide is treated with thionyl chloride to form N-(2-chloroethyl) -2-methoxy-4-amino-5-chlorobenzamide, which is reacted with diethylamine to form N-(diethyl-aminoethyl)-2-methoxy-4-amino-5-chlorobenzamide, which is optionally converted into an acid addition salt or a quaternary ammonium salt. 2. Fremgangsmåte ifølge krav 1, karakterisert ved at det som ester anvendes methyl-2-methoxy-4-acetamino-5-klorbenzoat.2. Method according to claim 1, characterized in that methyl-2-methoxy-4-acetamino-5-chlorobenzoate is used as ester.
NO2498/73A 1972-06-20 1973-06-15 NO135092C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7222288A FR2277815A1 (en) 1972-06-20 1972-06-20 NEW PROCESS FOR THE PREPARATION OF N (DIETHYLAMINOETHYL) 2-METHOXY 4-AMINO 5-CHLOROBENZAMIDE

Publications (2)

Publication Number Publication Date
NO135092B true NO135092B (en) 1976-11-01
NO135092C NO135092C (en) 1977-02-09

Family

ID=9100526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2498/73A NO135092C (en) 1972-06-20 1973-06-15

Country Status (26)

Country Link
JP (3) JPS5522468B2 (en)
KR (1) KR780000231B1 (en)
AT (1) AT350044B (en)
AU (1) AU468921B2 (en)
BE (1) BE801038A (en)
BG (3) BG20570A3 (en)
CA (1) CA1001170A (en)
CH (1) CH568277A5 (en)
CS (1) CS167389B2 (en)
DD (1) DD107441A5 (en)
DE (1) DE2330373A1 (en)
DK (1) DK131030B (en)
ES (1) ES415952A1 (en)
FI (1) FI56677C (en)
FR (1) FR2277815A1 (en)
GB (1) GB1395131A (en)
HU (1) HU166936B (en)
IE (1) IE37800B1 (en)
IL (1) IL42499A (en)
LU (1) LU67805A1 (en)
MC (1) MC1007A1 (en)
NO (1) NO135092C (en)
RO (1) RO64465A (en)
SE (5) SE402452B (en)
YU (1) YU36691B (en)
ZA (1) ZA734127B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5881689U (en) * 1981-11-25 1983-06-02 富士電機冷機株式会社 Cup type vending machine
JPS59155682U (en) * 1983-04-05 1984-10-19 東芝機器株式会社 beverage vending machine
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
JPH02148390A (en) * 1988-11-30 1990-06-07 Fuji Electric Co Ltd Automatic vending machine for hot commodity
US10539725B2 (en) 2016-11-30 2020-01-21 Samsung Electronics Co., Ltd. Optical filter and camera module and electronic device
CN113698321B (en) * 2021-09-30 2023-04-18 内蒙古康普药业有限公司 New metoclopramide diamine impurity and application

Also Published As

Publication number Publication date
JPS553340B2 (en) 1980-01-24
YU36691B (en) 1984-08-31
DD107441A5 (en) 1974-08-05
FR2277815B1 (en) 1978-10-20
RO64465A (en) 1979-05-15
JPS5070334A (en) 1975-06-11
CS167389B2 (en) 1976-04-29
BE801038A (en) 1973-12-18
JPS5070333A (en) 1975-06-11
HU166936B (en) 1975-06-28
SE7607356L (en) 1976-06-28
ATA531673A (en) 1978-10-15
AU5699473A (en) 1974-12-19
JPS4985039A (en) 1974-08-15
CA1001170A (en) 1976-12-07
BG22073A3 (en) 1976-11-25
SE7602735L (en) 1976-02-27
FI56677C (en) 1980-03-10
AU468921B2 (en) 1976-01-29
IE37800L (en) 1973-12-20
DK131030C (en) 1975-10-20
NO135092C (en) 1977-02-09
MC1007A1 (en) 1974-10-18
AT350044B (en) 1979-05-10
JPS5522468B2 (en) 1980-06-17
IE37800B1 (en) 1977-10-12
CH568277A5 (en) 1975-10-31
LU67805A1 (en) 1974-07-10
SE7602736L (en) 1976-02-27
SE402452B (en) 1978-07-03
BG22074A3 (en) 1976-11-25
JPS553341B2 (en) 1980-01-24
ES415952A1 (en) 1976-02-01
FI56677B (en) 1979-11-30
SE421069B (en) 1981-11-23
BG20570A3 (en) 1975-12-05
IL42499A0 (en) 1973-08-29
FR2277815A1 (en) 1976-02-06
SE421070B (en) 1981-11-23
DK131030B (en) 1975-05-20
ZA734127B (en) 1974-05-29
GB1395131A (en) 1975-05-21
KR780000231B1 (en) 1978-07-01
YU160773A (en) 1982-06-18
SE7607357L (en) 1976-06-28
IL42499A (en) 1976-11-30
DE2330373A1 (en) 1974-01-17

Similar Documents

Publication Publication Date Title
US2441498A (en) Alkyl glycinanilides
SU578870A3 (en) Method of preparing n-(methoxymethyl)furilmethyl-6,7-benzomorphanes or morhinanes or their salts
US2955111A (en) Synthesis of n-alkyl-piperidine and n-alkyl-pyrrolidine-alpha-carboxylic acid amides
US2654738A (en) Organic derivatives of phosphonic acids and method of preparing the same
NO135092B (en)
US2643255A (en) Method of preparing piperazine compounds and a new type of compound produced thereby
FI59086C (en) FOERFARANDE FOER FRAMSTAELLNING AV 2,5-DISUBSTITUERADE BENSAMIDER
US2819305A (en) Aminoalkylamides of butoxybenzoic acid
NO130549B (en)
US2519530A (en) Biotin aliphatic amides and method for their preparation
US3101345A (en) 2-hydroxymethyl-8-hydroxy-1,4-benzodioxane
CA1055502A (en) Process for the preparation of 2,5-disubstituted benzamides
US3352904A (en) Nu-carboxyalkyl-(2-methylenealkanoyl) aniline compounds
US3378592A (en) Process for the production of 3, 4-dihydroxybenzyloxyaminehydrobromide
US4001284A (en) Process for the manufacture of 5-sulfamoyl-anthranilic acids
US3433802A (en) 3-(n-lower-alkylanilino)pyrrolidines
US2916495A (en) Beta-thianaphthenylalkyl hydrazines and intermediates
EP0219225B1 (en) Process for the preparation of ranitidine or acid addition salts thereof, and intermediates for this preparation
US2559546A (en) 3-pyridoxy-alkanoic acid compounds
US2538139A (en) Biotin derivatives and processes of preparing the same
SU437294A1 (en) The method of obtaining derivatives of 2-amino-dihydro-benzodiazepinone
US3103520A (en) Aminobenzoxacycloalkanes
US3072722A (en) Preparation of amides of 4-tertiary amino-lower 4-alkylbutyric acids
SU468405A3 (en) Method for preparing organo-guanidine thiol esters
SU471713A3 (en) The method of obtaining - / aminophenyl / aliphatic derivatives of carboxylic acids or their salts, or their oxides